AAAAAA
Results: 1-25/27
Authors:
Siva, A
Kantarci, O
Citation: A. Siva et O. Kantarci, An introduction to the clinical spectrum of inflammatory demyelinating disorders of the central nervous system, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 1-9
Authors:
Allen, IV
Citation: Iv. Allen, Asymptomatic multiple sclerosis: what does it mean?, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 11-14
Authors:
Polman, CH
Citation: Ch. Polman, Monophasic isolated inflammatory demyelinating syndromes, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 15-18
Authors:
Comi, G
Martinelli, V
Filippi, M
Leocani, L
Rodegher, M
Rovaris, M
Martino, G
Citation: G. Comi et al., How early can we estimate transition into the progressive course from relapsing-remitting multiple sclerosis?, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 19-27
Authors:
Thompson, AJ
Citation: Aj. Thompson, Differences between primary and secondary progressive multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 29-36
Authors:
Weinshenker, BG
Miller, D
Citation: Bg. Weinshenker et D. Miller, Multiple sclerosis: one disease or many?, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 37-46
Authors:
Paty, DW
Li, DKB
Citation: Dw. Paty et Dkb. Li, Diagnosis of multiple sclerosis 1998: do we need new diagnostic criteria?, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 47-50
Authors:
Robertson, NP
Compston, DAS
Citation: Np. Robertson et Das. Compston, Prognosis in multiple sclerosis: genetic factors, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 51-61
Authors:
Confavreux, C
Citation: C. Confavreux, Clinical predictive factors in multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 63-66
Authors:
Eraksoy, M
Citation: M. Eraksoy, Multiple sclerosis in children: a review, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 67-73
Authors:
Koch-Henriksen, N
Bronnum-Hansen, H
Citation: N. Koch-henriksen et H. Bronnum-hansen, Survival in multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 75-84
Authors:
Archelos, JJ
Hartung, HP
Citation: Jj. Archelos et Hp. Hartung, Adhesion molecules in multiple sclerosis: a review, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 85-116
Authors:
Rieckmann, P
Kallmann, B
Citation: P. Rieckmann et B. Kallmann, Immunological parameters and magnetic resonance imaging activity, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 117-125
Authors:
Miller, A
Shapiro, S
Lahat, N
Citation: A. Miller et al., Immunomodulation in multiple sclerosis and cytokine response, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 127-138
Authors:
Olsson, T
Citation: T. Olsson, Future prospects of cytokines in the pathogenesis and management of multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 139-150
Authors:
Myers, LW
Ellison, GW
Leake, BD
Mickey, MR
Citation: Lw. Myers et al., Selection of patients for therapeutic clinical trials in multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 151-160
Authors:
Montalban, X
Citation: X. Montalban, Placebo-controlled trials: are they still needed or indeed ethical in multiple sclerosis?, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 161-165
Authors:
Lublin, FD
Citation: Fd. Lublin, Interferon beta-responders versus non-responders, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 167-172
Authors:
Andersen, O
Citation: O. Andersen, Treatment alternatives in relapsing-remitting multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 173-194
Authors:
Karussis, DM
Abramsky, O
Citation: Dm. Karussis et O. Abramsky, How to treat progressive multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 195-215
Authors:
Blumhardt, LD
Citation: Ld. Blumhardt, Clinical results and outcome measures from the multiple sclerosis PRISMS study, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 217-222
Authors:
Paty, DW
Li, DKB
Citation: Dw. Paty et Dkb. Li, Magnetic resonance techniques for monitoring multiple sclerosis pathology in clinical trials, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 223-228
Authors:
Clanet, M
Citation: M. Clanet, Combination therapy in multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 229-233
Authors:
Anthony, DC
Esiri, MM
Perry, VH
Citation: Dc. Anthony et al., Evidence of early axonal damage in multiple sclerosis lesions and its implications for therapeutic intervention, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 235-242
Authors:
Kesselring, J
Citation: J. Kesselring, Long-term management and rehabilitation in multiple sclerosis, FRONTIERS IN MULTIPLE SCLEROSIS, VOL 2, 1999, pp. 243-252